too early for licensing deal (imo)
good to pay attention to what else is going on coz ATX doesn’t operate in a vacuum. Several FAK inhibitors in development, the one from Verastem oncology looks the most advanced. They also tout theirs as “best in class”!!
- Forums
- ASX - By Stock
- Ann: Update on ACCENT Trial in Pancreatic Cancer
too early for licensing deal (imo) good to pay attention to what...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATX (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.5¢ |
Change
-0.002(2.99%) |
Mkt cap ! $17.65M |
Open | High | Low | Value | Volume |
6.5¢ | 6.5¢ | 6.5¢ | $9.75K | 150.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 26399 | 6.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.6¢ | 168536 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 26399 | 0.062 |
4 | 60000 | 0.060 |
1 | 17358 | 0.058 |
1 | 79000 | 0.057 |
1 | 17978 | 0.056 |
Price($) | Vol. | No. |
---|---|---|
0.066 | 168536 | 2 |
0.067 | 6935 | 2 |
0.068 | 157750 | 1 |
0.070 | 6009 | 1 |
0.074 | 73026 | 1 |
Last trade - 10.35am 20/06/2024 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online